These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26217075)

  • 1. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
    Bordonaro M; Lazarova DL
    World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells.
    Bordonaro M; Lazarova DL
    JMIR Res Protoc; 2016 May; 5(2):e66. PubMed ID: 27177606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
    Lazarova D; Bordonaro M
    J Cancer; 2017; 8(8):1453-1459. PubMed ID: 28638460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p300 Influences Butyrate-Mediated WNT Hyperactivation In Colorectal Cancer Cells.
    Lazarova DL; Wong T; Chiaro C; Drago E; Bordonaro M
    J Cancer; 2013; 4(6):491-501. PubMed ID: 23901349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBP Activity Mediates Effects of the Histone Deacetylase Inhibitor Butyrate on WNT Activity and Apoptosis in Colon Cancer Cells.
    Lazarova DL; Chiaro C; Wong T; Drago E; Rainey A; O'Malley S; Bordonaro M
    J Cancer; 2013; 4(6):481-90. PubMed ID: 23901348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesis: Sam68 and Pygo2 mediate cell type-specific effects of the modulation of CBP-Wnt and p300-Wnt activities in Colorectal Cancer Cells.
    Bordonaro M
    J Cancer; 2021; 12(16):5046-5052. PubMed ID: 34234873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Wnt Activity and Cell Physiology by Butyrate in LT97 Microadenoma Cells.
    Lazarova D; Lee A; Wong T; Marian B; Chiaro C; Rainey C; Bordonaro M
    J Cancer; 2014; 5(3):203-13. PubMed ID: 24563675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil targets histone acetyltransferases p300/CBP in the treatment of colorectal cancer.
    Du C; Huang D; Peng Y; Yao Y; Zhao Y; Yang Y; Wang H; Cao L; Zhu WG; Gu J
    Cancer Lett; 2017 Aug; 400():183-193. PubMed ID: 28465257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CBP and p300: Emerging Anticancer Agents.
    Masci D; Puxeddu M; Silvestri R; La Regina G
    Molecules; 2024 Sep; 29(19):. PubMed ID: 39407454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further analysis of p300 in mediating effects of Butyrate in Colorectal Cancer Cells.
    Bordonaro M
    J Cancer; 2020; 11(20):5861-5866. PubMed ID: 32922528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p300 Knockout Promotes Butyrate Resistance.
    Lazarova DL; Bordonaro M
    J Cancer; 2017; 8(17):3405-3409. PubMed ID: 29151923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vimentin, colon cancer progression and resistance to butyrate and other HDACis.
    Lazarova DL; Bordonaro M
    J Cell Mol Med; 2016 Jun; 20(6):989-93. PubMed ID: 27072512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fiber, cancer stem cells, and the Wnt signaling continuum: possibilities for colorectal cancer prevention and therapeutics].
    Bordonaro M; Sartorelli AC
    Ai Zheng; 2008 Jul; 27(7):766-70. PubMed ID: 18606074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors.
    Bordonaro M; Lazarova DL; Sartorelli AC
    Exp Cell Res; 2007 May; 313(8):1652-66. PubMed ID: 17359971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic and Receptor-Mediated Wnt Signaling Influence the Sensitivity of Colonic Cells to Butyrate.
    Bordonaro M
    J Cancer; 2023; 14(3):446-453. PubMed ID: 36860917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive suppression of all apoptosis-induced proliferation pathways as a proposed approach to colorectal cancer prevention and therapy.
    Bordonaro M; Drago E; Atamna W; Lazarova DL
    PLoS One; 2014; 9(12):e115068. PubMed ID: 25500581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300.
    Hyndman BD; Thompson P; Bayly R; Côté GP; LeBrun DP
    Biochim Biophys Acta; 2012 May; 1819(5):446-53. PubMed ID: 22387215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.